361 results on '"Durst R"'
Search Results
2. Technical activities 1985 : Center for Analytical Chemistry
- Author
-
Durst, R. A.
- Published
- 1985
3. FEEDING ECOLOGY OF APOCYCLOPS PROCERUS (COPEPODA, CYCLOPOIDA) UNDER EXPERIMENTAL CONDITIONS
- Author
-
GUENTHER, M., DURST, R., FELISMINO, W. S., PESSOA, V. T., and NEUMANN-LEITÃO, S.
- Published
- 2015
4. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)
- Author
-
Zhubi-Bakija, F., Bajraktari, G., Bytyci, I., Mikhailidis, D. P., Henein, M. Y., Latkovskis, G., Rexhaj, Z., Zhubi, E., Banach, M., Alnouri, F., Amar, F., Atanasov, A. G., Bartlomiejczyk, M. A., Bjelakovic, B., Bruckert, E., Cafferata, A., Ceska, R., Cicero, A. F. G., Collet, X., Descamps, O., Djuric, D., Durst, R., Ezhov, M. V., Fras, Z., Gaita, D., Hernandez, A. V., Jones, S. R., Jozwiak, J., Kakauridze, N., Katsiki, N., Khera, A., Kostner, K., Kubilius, R., Mancini, G. B. J., Marais, A. D., Martin, S. S., Martinez, J. A., Mazidi, M., Mirrakhimov, E., Miserez, A. R., Mitchenko, O., Moriarty, P. M., Nabavi, S. M., Nair, D., Panagiotakos, D. B., Paragh, G., Pella, D., Penson, P. E., Petrulioniene, Z., Pirro, M., Postadzhiyan, A., Puri, R., Reda, A., Reiner, Riadh, J., Richter, D., Rizzo, M., Ruscica, M., Sahebkar, A., Sattar, N., Serban, M. -C., Shehab, A. M. A., Shek, A. B., Sirtori, C. R., Stefanutti, C., Tomasik, T., Toth, P. P., Viigimaa, M., Vinereanu, D., Vohnout, B., von Haehling, S., Vrablik, M., Wong, N. D., Yeh, H. -I., Zhisheng, J., Zirlik, A., Zhubi-Bakija F, Bajraktari G, Bytyçi I, Mikhailidis DP, Henein MY, Latkovskis G, Rexhaj Z, Zhubi E, Banach M, International Lipid Expert Panel (ILEP), Cicero AFG, Zhubi-Bakija F., Bajraktari G., Bytyci I., Mikhailidis D.P., Henein M.Y., Latkovskis G., Rexhaj Z., Zhubi E., Banach M., Alnouri F., Amar F., Atanasov A.G., Bartlomiejczyk M.A., Bjelakovic B., Bruckert E., Cafferata A., Ceska R., Cicero A.F.G., Collet X., Descamps O., Djuric D., Durst R., Ezhov M.V., Fras Z., Gaita D., Hernandez A.V., Jones S.R., Jozwiak J., Kakauridze N., Katsiki N., Khera A., Kostner K., Kubilius R., Mancini G.B.J., Marais A.D., Martin S.S., Martinez J.A., Mazidi M., Mirrakhimov E., Miserez A.R., Mitchenko O., Moriarty P.M., Nabavi S.M., Nair D., Panagiotakos D.B., Paragh G., Pella D., Penson P.E., Petrulioniene Z., Pirro M., Postadzhiyan A., Puri R., Reda A., Reiner, Riadh J., Richter D., Rizzo M., Ruscica M., Sahebkar A., Sattar N., Serban M.-C., Shehab A.M.A., Shek A.B., Sirtori C.R., Stefanutti C., Tomasik T., Toth P.P., Viigimaa M., Vinereanu D., Vohnout B., von Haehling S., Vrablik M., Wong N.D., Yeh H.-I., Zhisheng J., Zirlik A., and UCL - (SLuc) Service de pathologie cardiovasculaire
- Subjects
Adult ,Male ,Dietary protein ,Weight loss ,Cardiometabolic Risk Factors ,food and beverages ,Middle Aged ,Recommended Dietary Allowances ,Cardiovascular disease ,Plant Proteins, Dietary ,Cardiovascular disease, Cholesterol, Dietary protein, Metabolic syndrome, Weight loss, Adult, Aged, Animal Proteins, Dietary, Cardiometabolic Risk Factors, Cardiovascular Diseases, Diet, Healthy, Expert Testimony, Female, Humans, Male, Middle Aged, Plant Proteins, Dietary, Young Adult, Recommended Dietary Allowances ,Metabolic syndrome ,Young Adult ,Cholesterol ,Cardiovascular Diseases ,Animal Proteins, Dietary ,Humans ,Female ,Diet, Healthy ,Expert Testimony ,Aged - Abstract
Proteins play a crucial role in metabolism, in maintaining fluid and acid-base balance and antibody synthesis. Dietary proteins are important nutrients and are classified into: 1) animal proteins (meat, fish, poultry, eggs and dairy), and, 2) plant proteins (legumes, nuts and soy). Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular (CV) disease (CVD) by attenuating related risk factors. The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat, animal proteins and plant proteins. In view of the available evidence, it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health. Such healthy diets are thought to increase satiety, facilitate weight loss, and improve CV risk. Different studies have compared the benefits of omnivorous and vegetarian diets. Animal protein related risk has been suggested to be greater with red or processed meat over and above poultry, fish and nuts, which carry a lower risk for CVD. In contrast, others have shown no association of red meat intake with CVD. The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors. Many observational and interventional studies confirmed that increasing protein intake, especially plant-based proteins and certain animal-based proteins (poultry, fish, unprocessed red meat low in saturated fats and low-fat dairy products) have a positive effect in modifying cardiometabolic risk factors. Red meat intake correlates with increased CVD risk, mainly because of its non-protein ingredients (saturated fats). However, the way red meat is cooked and preserved matters. Thus, it is recommended to substitute red meat with poultry or fish in order to lower CVD risk. Specific amino acids have favourable results in modifying major risk factors for CVD, such as hypertension. Apart from meat, other animal-source proteins, like those found in dairy products (especially whey protein) are inversely correlated to hypertension, obesity and insulin resistance.
- Published
- 2021
5. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis
- Author
-
Cicero A. F. G., Fogacci F., Hernandez A. V., Banach M., Alnouri F., Amar F., Atanasov A. G., Bajraktari G., Bartlomiejczyk M. A., Bjelakovic B., Bruckert E., Bielecka-Dabrowa A., Cafferata A., Ceska R., Collet X., Descamps O., Devaki N., Djuric D., Durst R., Ezhov M. V., Fras Z., Gaita D., von Haehling S., Jones S. R., Jozwiak J., Kakauridze N., Katsiki N., Khera A., Kostner K., Kubilius R., Latkovskis G., Mancini G. B. J., Marais A. D., Martin S. S., Martinez J. A., Mazidi M., Mikhailidis D. P., Mirrakhimov E., Miserez A. R., Mitchenko O., Moriarty P., Nabavi S. M., Panagiotakos D. B., Paragh G., Pella D., Penson P. E., Petrulioniene Z., Pirro M., Postadzhiyan A., Puri R., Reda A., Reiner Z., Riadh J., Richter D., Rizzo M., Ruscica M., Sahebkar A., Sattar N., Serban M. C., Shehab A. M. A., Shek A. B., Sirtori C. R., Stefanutti C., Tomasik T., Toth P. P., Viigimaa M., Vinereanu D., Vohnout B., Vrablik M., Wong N. D., Yeh H. I., Zhisheng J., Zirlik A., Cicero A.F.G., Fogacci F., Hernandez A.V., Banach M., Alnouri F., Amar F., Atanasov A.G., Bajraktari G., Bartlomiejczyk M.A., Bjelakovic B., Bruckert E., Bielecka-Dabrowa A., Cafferata A., Ceska R., Collet X., Descamps O., Devaki N., Djuric D., Durst R., Ezhov M.V., Fras Z., Gaita D., von Haehling S., Jones S.R., Jozwiak J., Kakauridze N., Katsiki N., Khera A., Kostner K., Kubilius R., Latkovskis G., Mancini G.B.J., Marais A.D., Martin S.S., Martinez J.A., Mazidi M., Mikhailidis D.P., Mirrakhimov E., Miserez A.R., Mitchenko O., Moriarty P., Nabavi S.M., Panagiotakos D.B., Paragh G., Pella D., Penson P.E., Petrulioniene Z., Pirro M., Postadzhiyan A., Puri R., Reda A., Reiner Z., Riadh J., Richter D., Rizzo M., Ruscica M., Sahebkar A., Sattar N., Serban M.C., Shehab A.M.A., Shek A.B., Sirtori C.R., Stefanutti C., Tomasik T., Toth P.P., Viigimaa M., Vinereanu D., Vohnout B., Vrablik M., Wong N.D., Yeh H.I., Zhisheng J., Zirlik A., Wierzbicki, Anthony, Penson, P, and Cicero AF, Fogacci F, Hernandez AV, Banach M
- Subjects
Apolipoprotein B ,Publication Ethics ,030204 cardiovascular system & hematology ,Cardiovascular ,Gastroenterology ,Lipoprotein particle ,Medical and Health Sciences ,Biochemistry ,chemistry.chemical_compound ,Database and Informatics Methods ,0302 clinical medicine ,Mathematical and Statistical Techniques ,Anticholesteremic Agents, Apolipoproteins B, Cholesterol, Cholesterol, LDL, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Dicarboxylic Acids, Fatty Acids, Humans, Hypercholesterolemia, Peptide Fragments, Randomized Controlled Trials as Topic ,Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel ,Medicine and Health Sciences ,Dicarboxylic Acids ,030212 general & internal medicine ,Database Searching ,Research Integrity ,Randomized Controlled Trials as Topic ,medicine.diagnostic_test ,biology ,Anticholesteremic Agents ,Statistics ,Fatty Acids ,Drugs ,General Medicine ,Metaanalysis ,Serious Mental Illness ,Lipids ,Phase III as Topic ,Mental Health ,Cholesterol ,Physical Sciences ,Medicine ,Research Article ,medicine.medical_specialty ,RM ,Science Policy ,Lipoproteins ,Hypercholesterolemia ,Bempedoic acid, hypercholesterolemia, lipid profile, hsCRP ,Research and Analysis Methods ,LDL ,03 medical and health sciences ,Clinical Trials, Phase II as Topic ,Internal medicine ,General & Internal Medicine ,medicine ,Humans ,Clinical Trials ,Statistical Methods ,Apolipoproteins B ,Pharmacology ,Plasma Proteins ,business.industry ,Phase II as Topic ,Statins ,Biology and Life Sciences ,Proteins ,Odds ratio ,Cholesterol, LDL ,Confidence interval ,Peptide Fragments ,chemistry ,Clinical Trials, Phase III as Topic ,biology.protein ,Uric acid ,Creatine kinase ,Lipid profile ,business ,Digestive Diseases ,Mathematics - Abstract
Background Bempedoic acid is a first-in-class lipid-lowering drug recommended by guidelines for the treatment of hypercholesterolemia. Our objective was to estimate its average effect on plasma lipids in humans and its safety profile. Methods and findings We carried out a systematic review and meta-analysis of phase II and III randomized controlled trials on bempedoic acid (PROSPERO: CRD42019129687). PubMed (Medline), Scopus, Google Scholar, and Web of Science databases were searched, with no language restriction, from inception to 5 August 2019. We included 10 RCTs (n = 3,788) comprising 26 arms (active arm [n = 2,460]; control arm [n = 1,328]). Effect sizes for changes in lipids and high-sensitivity C-reactive protein (hsCRP) serum concentration were expressed as mean differences (MDs) and 95% confidence intervals (CIs). For safety analyses, odds ratios (ORs) and 95% CIs were calculated using the Mantel–Haenszel method. Bempedoic acid significantly reduced total cholesterol (MD −14.94%; 95% CI −17.31%, −12.57%; p < 0.001), non-high-density lipoprotein cholesterol (MD −18.17%; 95% CI −21.14%, −15.19%; p < 0.001), low-density lipoprotein cholesterol (MD −22.94%; 95% CI −26.63%, −19.25%; p < 0.001), low-density lipoprotein particle number (MD −20.67%; 95% CI −23.84%, −17.48%; p < 0.001), apolipoprotein B (MD −15.18%; 95% CI −17.41%, −12.95%; p < 0.001), high-density lipoprotein cholesterol (MD −5.83%; 95% CI −6.14%, −5.52%; p < 0.001), high-density lipoprotein particle number (MD −3.21%; 95% CI −6.40%, −0.02%; p = 0.049), and hsCRP (MD −27.03%; 95% CI −31.42%, −22.64%; p < 0.001). Bempedoic acid did not significantly modify triglyceride level (MD −1.51%; 95% CI −3.75%, 0.74%; p = 0.189), very-low-density lipoprotein particle number (MD 3.79%; 95% CI −9.81%, 17.39%; p = 0.585), and apolipoprotein A-1 (MD −1.83%; 95% CI −5.23%, 1.56%; p = 0.290). Treatment with bempedoic acid was positively associated with an increased risk of discontinuation of treatment (OR 1.37; 95% CI 1.06, 1.76; p = 0.015), elevated serum uric acid (OR 3.55; 95% CI 1.03, 12.27; p = 0.045), elevated liver enzymes (OR 4.28; 95% CI 1.34, 13.71; p = 0.014), and elevated creatine kinase (OR 3.79; 95% CI 1.06, 13.51; p = 0.04), though it was strongly associated with a decreased risk of new onset or worsening diabetes (OR 0.59; 95% CI 0.39, 0.90; p = 0.01). The main limitation of this meta-analysis is related to the relatively small number of individuals involved in the studies, which were often short or middle term in length. Conclusions Our results show that bempedoic acid has favorable effects on lipid profile and hsCRP levels and an acceptable safety profile. Further well-designed studies are needed to explore its longer-term safety., Maciej Banach and colleagues discuss the efficacy and safety of bempedoic acid, a drug that designed to lower LDL-C levels., Author summary Why was this study done? Lowering low-density lipoprotein cholesterol (LDL-C) is effective for reducing cardiovascular events over time. A number of phase II and phase III randomized controlled trials (RCTs) are already available showing encouraging results of bempedoic acid treatment on LDL-C. We aimed to perform a systematic review and meta-analysis on the clinical evidence available to date to better define the efficacy and tolerability profile of treatment with bempedoic acid. What did the researchers do and find? In this analysis of bempedoic acid that included 10 randomized clinical trials (n = 3,788 patients) comprising 26 arms (active arm [n = 2,460]; control arm [n = 1,328]), we confirmed that bempedoic acid significantly reduced total cholesterol (by 15%), non-high-density lipoprotein cholesterol (by 18.2%), LDL-C (by 22.9%), low-density lipoprotein particle number (by 20.7%), apolipoprotein B (by 15.2%), and high-sensitivity C-reactive protein (hsCRP) (by 27%), while negatively affecting serum levels of high-density lipoprotein cholesterol (−5.8%) and high-density lipoprotein particle number (−3.2%). Our results also confirmed that the therapy is overall safe and well tolerated, with no significant increase of serious adverse effects. What do these findings mean? The current meta-analysis demonstrates the multiple positive effects of bempedoic acid on lipid profile and hsCRP serum levels, as well as acceptable safety profile. This could be relevant in a setting where statin intolerance is very frequent and the LDL-C target suggested by international guidelines for dyslipidemia management is hard to achieve with standard therapies. An ongoing long-term cardiovascular outcomes trial will answer questions on the effect of bempedoic acid on cardiovascular events and mortality as well as on the drug’s safety issues.
- Published
- 2020
6. Signalling processes involved in C-peptide-induced chemotaxis of CD4-positive lymphocytes
- Author
-
Aleksic, M., Walcher, D., Giehl, K., Bach, H., Grüb, M., Durst, R., Hombach, V., and Marx, N.
- Published
- 2009
- Full Text
- View/download PDF
7. Variability of Phytonutrient Content of Potato in Relation to Growing Location and Cooking Method
- Author
-
Brown, C. R., Durst, R. W., Wrolstad, R., and De Jong, W.
- Published
- 2008
- Full Text
- View/download PDF
8. Tangier disease in Israel; Complicated by mobile lipomatous mass on mitral valve and acute stroke
- Author
-
Durst, R., Shpitzen, S., Mowaswes, M., Schurr, D., and Leitersdorf, E.
- Published
- 2023
- Full Text
- View/download PDF
9. Genetic and humoral characteristics of patients with moderate and severe hypertriglyceridemia without secondary etiology
- Author
-
Durst, R., Cederboim, S. Horowitz, Shpitzen, S., Mowaswes, M., Schurr, D., and Leitersdorf, E.
- Published
- 2023
- Full Text
- View/download PDF
10. Oxygen-doped ZnTe phosphors for synchrotron X-ray imaging detectors
- Author
-
Kang, Z. T., Menkara, H., Wagner, B. K., Summers, C. J., Durst, R., Diawara, Y., Mednikova, G., and Thorson, T.
- Published
- 2006
- Full Text
- View/download PDF
11. Breeding studies in potatoes containing high concentrations of anthocyanins
- Author
-
Brown, C. R., Wrolstad, R., Durst, R., Yang, C. -P., and Clevidence, B.
- Published
- 2003
- Full Text
- View/download PDF
12. A novel gas-filled detector for synchrotron radiation applications
- Author
-
Kocsis, Menyhert, Boesecke, P., Carbone, D., Herve, C., Becker, B., Diawara, Y., Durst, R., Khazins, D., He, B., Medved, S., Sedov, V., Thorson, T., and Wachter, G.
- Published
- 2006
- Full Text
- View/download PDF
13. Effects of annealing atmosphere on the luminescent efficiency of ZnTe:O phosphors
- Author
-
Kang, Z.T., Menkara, H., Wagner, B.K., Summers, C.J., Durst, R., Diawara, Y., Mednikova, G., and Thorson, T.
- Published
- 2006
- Full Text
- View/download PDF
14. The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients
- Author
-
Durst, R., Jansen, A., Erez, G., Bravdo, R., Butbul, E., Ben Avi, L., Shpitzen, S., Lotan, C., Leitersdorf, E., Defesche, J., Friedlander, Y., Meiner, V., and Miserez, A.R.
- Published
- 2006
- Full Text
- View/download PDF
15. Post-partum hypocalcemia: Idiopatic hypoparathyroidism manifested early in lactation
- Author
-
Durst, R., Meirovitz, A., Gross, D., Kolker, O., and Muszkat, M.
- Published
- 2002
- Full Text
- View/download PDF
16. Symptomatic improvement after mesh removal: a prospective longitudinal study of women with urogynaecological mesh complications.
- Author
-
Pace, N, Artsen, A, Baranski, L, Palcsey, S, Durst, R, Meyn, L, and Moalli, PA
- Subjects
PELVIC pain ,VAGINAL surgery ,SURGICAL excision ,SURGICAL meshes ,PSYCHOLOGICAL distress ,TREATMENT effectiveness ,LONGITUDINAL method ,VISUAL analog scale - Abstract
Objective: To compare clinical characteristics and outcomes in patients undergoing excision of polypropylene urogynaecological mesh for pain, mesh exposure or both. Design: Prospective, longitudinal cohort. Setting: Academic tertiary referral centre. Population: Women undergoing complete vaginal mesh excision for mesh exposure and/or pain. Methods: Clinical and patient‐reported outcomes assessing pain (visual analog scale, VAS), bother (Pelvic Floor Distress Inventory, PFDI) and functional impact (Pelvic Functional Impact Questionnaire, PFIQ) were collected at baseline, 6, 12 and 24 months after complete mesh excision. Outcomes were compared by mesh type (sling, prolapse [transvaginal or sacrocolpopexy mesh], both) and complication (pain, exposure, both). Main outcome measures: 'Much better' or 'Very much better' on Patient Global Impression of Improvement (PGI‐I) up to 2 years after removal. Results: Of 173 women, 48 underwent removal for pain, 27 for exposure and 98 for exposure plus pain. 'Moderate to severe' baseline symptoms were reported by 75%; the most prevalent and severe symptom was dyspareunia. Patients with pain alone were most bothered (PFDI median 234.2, interquartile range 83, P = 0.02) and had the highest functional impact (PFIQ median 181, interquartile range 138, P < 0.001). After excision, only 33.3% of women with pain alone reported 'improved' symptoms (PGI‐I), versus 73.9% with exposure, 58.3% with exposure plus pain (P = 0.03) with no differences in PGI‐I by mesh type. VAS scores decreased in all groups, but PFDI and PFIQ did not improve in pain patients. Conclusions: In women experiencing a pain complication after urogynaecological mesh insertion, mesh removal often does not improve symptoms. Only 33% of women with pain complications have improved symptoms after urogynaecological mesh removal. Only 33% of women with pain complications have improved symptoms after urogynaecological mesh removal. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa
- Author
-
Durst, R., Goldschmidt, N., and Ben Yehuda, A.
- Published
- 2002
18. InterPlanetary internet
- Author
-
Burleigh, S, Cerf, V, Durst, R, Fall, K, Scott, K, Torgerson, L, Weiss, H, and Hooke, A. J
- Published
- 2003
19. The interplanetary internet: a communications infrastructure for Mars exploration
- Author
-
Weiss, H, Scott, K, Fall, K, Durst, R, Cerf, V, Burleigh, S, and Hooke, A. J
- Abstract
This paper describes the architectural concepts, discusses the current set of standard data communications capabilities that exist to support Mars exploration and reviews the proposed new developments.
- Published
- 2002
20. The interplanetary internet: a communications infrastructure for Mars exploration
- Author
-
Hooke, A. J, Burleigh, S, Cerf, V, Durst, R, Fall, K, Scott, K, and Weiss, H
- Published
- 2002
21. Risperidone in treating behavioural disturbances of Prader-Willi syndrome
- Author
-
Durst, R, Rubin-Jabotinsky, K, Raskin, S, Katz, G, and Zislin, J
- Published
- 2000
22. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation
- Author
-
Raskin, S., Katz, G., Zislin, Z., Knobler, H. Y., and Durst, R.
- Published
- 2000
23. Rabbit syndrome treated with olanzapine
- Author
-
Durst, R, Katz, G., Zislin, J., Raskin, S., and Kalman, I.
- Published
- 2000
24. A chronic hypercoagulable state in patients with β-thalassaemia major is already present in childhood
- Author
-
Eldor, A., Durst, R., Hy-Am, E., Goldfarb, A., Gillis, S., Rachmilewitz, E. A., Abramov, A., Maclouf, J., Godefray, Y. C., de Raucourt, E., and Guillin, M. C.
- Published
- 1999
25. De novo jet-lag psychosis
- Author
-
Katz, G., Durst, R., Barel, Y. C., and Knobler, H. Y.
- Published
- 1999
26. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- Author
-
Vallejo-Vaz, A.J. Marco, M.D. Stevens, C.A.T. Akram, A. Freiberger, T. Hovingh, G.K. Kastelein, J.J.P. Mata, P. Raal, F.J. Santos, R.D. Soran, H. Watts, G.F. Abifadel, M. Aguilar-Salinas, C.A. Al-Khnifsawi, M. Alkindi, F.A. Alnouri, F. Alonso, R. Al-Rasadi, K. Al-Sarraf, A. Ashavaid, T.F. Binder, C.J. Bogsrud, M.P. Bourbon, M. Bruckert, E. Chlebus, K. Corral, P. Descamps, O. Durst, R. Ezhov, M. Fras, Z. Genest, J. Groselj, U. Harada-Shiba, M. Kayikcioglu, M. Lalic, K. Lam, C.S.P. Latkovskis, G. Laufs, U. Liberopoulos, E. Lin, J. Maher, V. Majano, N. Marais, A.D. März, W. Mirrakhimov, E. Miserez, A.R. Mitchenko, O. Nawawi, H.M. Nordestgaard, B.G. Paragh, G. Petrulioniene, Z. Pojskic, B. Postadzhiyan, A. Reda, A. Reiner, Ž. Sadoh, W.E. Sahebkar, A. Shehab, A. Shek, A.B. Stoll, M. Su, T.-C. Subramaniam, T. Susekov, A.V. Symeonides, P. Tilney, M. Tomlinson, B. Truong, T.-H. Tselepis, A.D. Tybjærg-Hansen, A. Vázquez-Cárdenas, A. Viigimaa, M. Vohnout, B. Widén, E. Yamashita, S. Banach, M. Gaita, D. Jiang, L. Nilsson, L. Santos, L.E. Schunkert, H. Tokgözoğlu, L. Car, J. Catapano, A.L. Ray, K.K. Schreier, L. Pang, J. Dieplinger, H. Hanauer-Mader, G. Desutter, J. Langlois, M. Mertens, A. Rietzschel, E. Wallemacq, C. Isakovic, D. Dzankovic, A.M. Obralija, J. Pojskic, L. Sisic, I. Stimjanin, E. Torlak, V.A. Jannes, C.E. Krieger, J.E. Pereira, A.C. Ruel, I. Asenjo, S. Cuevas, A. Pećin, I. Miltiadous, G. Panayiotou, A.G. Vrablik, M. Benn, M. Heinsar, S. Béliard, S. Gouni-Berthold, I. Hengstenberg, W. Julius, U. Kassner, U. Klose, G. König, C. König, W. Otte, B. Parhofer, K. Schatz, U. Schmidt, N. Steinhagen-Thiessen, E. Vogt, A. Antza, C. Athyros, V. Bilianou, E. Boufidou, A. Chrousos, G. Elisaf, M. Garoufi, A. Katsiki, N. Kolovou, G. Kotsis, V. Rallidis, L. Rizos, C. Skalidis, E. Skoumas, I. Tziomalos, K. Shawney, J.P.S. Abbaszadegan, M.R. Aminzadeh, M. Hosseini, S. Mobini, M. Vakili, R. Zaeri, H. Agar, R. Boran, G. Colwell, N. Crowley, V. Durkin, M. Griffin, D. Kelly, M. Rakovac-Tisdall, A. Bitzur, R. Cohen, H. Eliav, O. Ellis, A. Gavish, D. Harats, D. Henkin, Y. Knobler, H. Leavit, L. Leitersdorf, E. Schurr, D. Shpitzen, S. Szalat, A. Arca, M. Averna, M. Bertolini, S. Calandra, S. Tarugi, P. Erglis, A. Gilis, D. Nesterovics, G. Saripo, V. Upena-Roze, A. Elbitar, S. Jambart, S. Khoury, P.E. Gargalskaite, U. Kutkiene, S. Al-Khateeb, A. An, C.Y. Ismail, Z. Kasim, S. Ibrahim, K.S. Radzi, A.B.M. Kasim, N.A. Nor, N.S.M. Ramli, A.S. Razak, S.A. Muid, S. Rosman, A. Sanusi, A.R. Razman, A.Z. Nazli, S.A. Kek, T.L. Azzopardi, C. Aguilar Salinas, C.A. Galán, G. Rubinstein, A. Magaña-Torres, M.T. Martagon, A. Mehta, R. Wittekoek, M.E. Isara, A.R. Obaseki, D.E. Ohenhen, O.A. Holven, K.B. Gruchała, M. Baranowska, M. Borowiec-Wolny, J. Gilis-Malinowska, N. Michalska-Grzonkowska, A. Pajkowski, M. Parczewska, A. Romanowska-Kocejko, M. Stróżyk, A. Żarczyńska-Buchowiecka, M. Kleinschmidt, M. Alves, A.C. Medeiros, A.M. Ershova, A. Korneva, V. Kuznetsova, T. Malyshev, P. Meshkov, A. Rozhkova, T. Popovic, L. Lukac, S.S. Stosic, L. Rasulic, I. Lalic, N.M. Chua, T.S.J. Ting, S.P.L. Raslova, K. Battelino, T. Cevc, M. Jug, B. Kovac, J. Podkrajsek, K.T. Sustar, U. Trontelj, K.J. Marais, D. Isla, L.P. Martin, F.J. Charng, M.-J. Chen, P.-L. Kayikçioglu, M. Dell’oca, N. Fernández, G. Ressia, A. Reyes, X. Zelarayan, M. Alieva, R.B. Hoshimov, S.U. Nizamov, U.I. Kurbanov, R.D. Lima-Martínez, M.M. Nguyen, M.-N.T. Do, D.-L. Kim, N.-T. Le, T.-T. Le, H.-A.
- Abstract
Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey among the worldwide network of EAS FHSC Lead Investigators to provide an overview of FH status in different countries. Methods: Lead Investigators from countries formally involved in the EAS FHSC by mid-May 2018 were invited to provide a brief report on FH status in their countries, including available information, programmes, initiatives, and management. Results: 63 countries provided reports. Data on FH prevalence are lacking in most countries. Where available, data tend to align with recent estimates, suggesting a higher frequency than that traditionally considered. Low rates of FH detection are reported across all regions. National registries and education programmes to improve FH awareness/knowledge are a recognised priority, but funding is often lacking. In most countries, diagnosis primarily relies on the Dutch Lipid Clinics Network criteria. Although available in many countries, genetic testing is not widely implemented (frequent cost issues). There are only a few national official government programmes for FH. Under-treatment is an issue. FH therapy is not universally reimbursed. PCSK9-inhibitors are available in ∼2/3 countries. Lipoprotein-apheresis is offered in ∼60% countries, although access is limited. Conclusions: FH is a recognised public health concern. Management varies widely across countries, with overall suboptimal identification and under-treatment. Efforts and initiatives to improve FH knowledge and management are underway, including development of national registries, but support, particularly from health authorities, and better funding are greatly needed. © 2018 Elsevier B.V.
- Published
- 2018
27. Splenosis in exit gunshot wound
- Author
-
Burvin, R., Durst, R. Y., Ben-Arieh, Y., and Barzilay, A.
- Published
- 1996
28. A space demonstration of the next generation TT and C standards
- Author
-
Shave, N. P, Wells, N. S, Hooke, A, and Durst, R
- Subjects
Space Communications, Spacecraft Communications, Command And Tracking - Abstract
An initiative to develop an integrated set of space data communication protocols, which will complement and expand upon the current Consultative Committee for Space Data Systems (CCSDS) telemetry and telecommand standards, is reported on. The aim is to provide a comprehensive set of spacecraft control and monitoring data handling services. The space communications protocol standards (SCPS) initiative will provide a set of spacecraft telemetry, telecommand and control (TT and C) standards that will serve a wide range of civilian and military space missions. A software flight test and demonstration of the capabilities of the SCPS protocols was performed using the in orbit space technology research vehicle and compared to laboratory simulations. The results from this test will contribute to the continued SCPS protocol development program.
- Published
- 1996
29. Psychiatric aspects of jet lag: review and hypothesis
- Author
-
Katz, G., Durst, R., Zislin, Y., Barel, Y., and Knobler, H.Y.
- Published
- 2001
- Full Text
- View/download PDF
30. The characteristics of patients with possible familial hypercholesterolemia—screening a large payer/provider healthcare delivery system.
- Author
-
Elis, A, Leventer-Roberts, M, Bachrach, A, Lieberman, N, Durst, R, Knobler, H, and Balicer, R
- Subjects
MEDICAL personnel ,CARDIOVASCULAR diseases risk factors ,MEDICAL record databases ,HYPERCHOLESTEREMIA ,SINGLE-payer health care ,ELECTRONIC health records - Abstract
Background Familial hypercholesterolemia (FH) is an under-diagnosed condition. Aim We applied standard laboratory criteria across a large longitudinal electronic medical record database to describe cross-sectional population with possible FH. Methods A cross-sectional study of Clalit Health Services members. Subjects who met the General Population MED-PED laboratory criteria, excluding: age <10 years, documentation of thyroid, liver, biliary or autoimmune diseases, a history of chronic kidney disease stage 3 or greater, the presence of urine protein >300 mg/l, HDL-C>80 mg/dl, active malignancy or pregnancy at the time of testing were considered possible FH. Demographic and clinical characteristics are described at time of diagnosis and at a single index date following diagnosis to estimate the burden on the healthcare system. The patient population is also compared to the general population. Results The study cohort included 12 494 subjects with out of over 4.5 million members of Clalit Health Services. The estimated prevalence of FH in Israel was found to be 1:285. These patients are notably positive for, and have a family history of, cardiovascular disease and risk factors. For most of them the LDL-C levels are not controlled, and only a quarter of them are medically treated. Conclusions By using the modified MED-PED criteria in a large electronic database, patients with possible FH can be identified enabling early intervention and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. First tangier disease case in Ashkenazi Jews complicated by mobile lipomatous mass on mitral valve
- Author
-
Durst, R., Mowaswes, M., Shpitzen, S., Schurr, D., and Leitersdorf, E.
- Published
- 2020
- Full Text
- View/download PDF
32. Whole exome sequencing of familial hypercholesterolemia patients negative for LDL/APOB/PCSK9 mutations
- Author
-
Futema, M, Plagnol, V, Li, K, Whittall, Ra, Neil, Haw, Seed, M, Bertolini, Stefano, Calandra, S, D. e. s. c. a. m. p. s., . O. S, G. r. a. h. a. m., . C. A, H. e. g. e. l. e., . R. A, Karpe, F, Durst, R, Leitersdorf, E, Lench, N, N. a. i. r., . D. R, Soran, H, Van B. o. c. k. x. m. e. e. r., . F. M, and H. u. m. p. h. r. i. e. s., . S. E.
- Published
- 2014
33. The generation of psychosis: a pragmatic approach
- Author
-
Zislin, J, Kuperman, V, and Durst, R
- Published
- 2002
- Full Text
- View/download PDF
34. Recent D-T results on TFTR
- Author
-
Johnson, DW, Arunasalam, V, Barnes, CW, Batha, SH, Bateman, G, Beer, M, Bell, MG, Bell, R, Bitter, M, Bretz, NL, Budny, R, Bush, CE, Cauffman, S, Chang, CS, Chang, Z, Cheng, CZ, Darrow, DS, Dendy, R, Dorland, W, Duong, HH, Durst, R, Efthimion, PC, Ernst, D, Evenson, H, Fisch, N, Fisher, R, Fonck, RJ, Fredrickson, E, Fu, GY, Fujita, T, Furth, HP, Gorelenkov, N, Grek, B, Grisham, LR, Hammett, G, Hawryluk, RJ, Heidbrink, W, Herrmann, HW, Hill, KW, Hosea, J, Hsuan, H, Hughes, M, Janos, A, Jassby, DL, Jobes, FC, Johnson, LC, Kamperschroer, J, Kesner, J, Kotschenreuther, M, Kugel, H, Lamarche, PH, Leblanc, B, Levinton, FM, MacHuzak, J, Majeski, R, Mansfield, DK, Marmar, ES, Mazzucato, E, Mauel, M, McChesney, J, McGuire, KM, McKee, G, Meade, DM, Medley, SS, Mikkelsen, DR, Mirnov, SV, Mueller, D, Nazikian, R, Osakabe, M, Owens, DK, Park, H, Park, W, Parks, P, Paul, SF, Petrov, M, Phillips, CK, Phillips, M, Qualls, AL, Ramsey, A, Redi, MH, Rewoldt, G, Roberts, D, Rogers, J, Roquemore, AL, Ruskov, E, Sabbagh, SA, Sasao, M, Schilling, G, Schivell, J, Schmidt, GL, Scott, SD, Semenov, I, Sesnic, S, Skinner, CH, Spong, D, Stratton, BC, Strachan, JD, Stodiek, W, Synakowski, E, and Takahashi, H
- Subjects
Physics::Plasma Physics - Abstract
Routine tritium operation in TFTR has permitted investigations of alpha particle physics in parameter ranges resembling those of a reactor core. ICRF wave physics in a DT plasma and the influence of isotopic mass on supershot confinement have also been studied. Continued progress has been made in optimizing fusion power production in TFTR, using extended machine capability and Li wall conditioning. Performance is currently limited by MHD stability. A new reversed magnetic shear regime is being investigated with reduced core transport and a higher predicted stability limit.
- Published
- 1995
- Full Text
- View/download PDF
35. Plasma-surface interactions in TFTR DT experiments
- Author
-
Owens, DK, Adler, H, Alling, P, Ancher, C, Anderson, H, Anderson, JL, Ashcroft, D, Barnes, CW, Barnes, G, Batha, S, Bell, MG, Bell, R, Bitter, M, Blanchard, W, Bretz, NL, Budny, R, Bush, CE, Camp, R, Caorlin, M, Cauffman, S, Chang, Z, Cheng, CZ, Collins, J, Coward, G, Darrow, DS, DeLooper, J, Duong, H, Dudek, L, Durst, R, Efthimion, PC, Ernst, D, Fisher, R, Fonck, RJ, Fredrickson, E, Fromm, N, Fu, GY, Furth, HP, Gentile, C, Gorelenkov, N, Grek, B, Grisham, LR, Hammett, G, Hanson, GR, Hawryluk, RJ, Heidbrink, W, Hermann, HW, Hill, KW, Hosea, J, Hsuan, H, and Janos, A
- Subjects
inorganic chemicals - Abstract
TFTR has begun its campaign to study deuterium-tritium fusion under reactor-like conditions. Variable amounts of deuterium and tritium neutral beam power have been used to maximize fusion power, study alpha heating, investigate alpha particle confinement, and search for alpha driven plasma instabilities. Additional areas of study include energy and particle transport and confinement, ICRF heating schemes for DT plasmas, tritium retention, and fusion in high βp plasmas. The majority of this work is done in the TFTR supershot confinement regime. To obtain supershots, extensive limiter conditioning using helium fueled ohmic discharges and lithium pellet injection into ohmic and neutral beam heated plasmas is performed, resulting in a low recycling limiter. The relationship between recycling and core plasma confinement has been studied by using helium, deuterium and high-Z gas puffs to simulate high recycling limiter conditions. These studies show that confinement in TFTR supershots is very sensitive to the influx of neutral particles at the plasma edge. © 1995, All rights reserved.
- Published
- 1995
- Full Text
- View/download PDF
36. Coronary stent restenosis and the association with allergy to metal content of 316L stainless steel.
- Author
-
Slodownik, D., Danenberg, C., Merkin, D., Swaid, F., Moshe, S., Ingber, A., Lotan, H., and Durst, R.
- Published
- 2018
- Full Text
- View/download PDF
37. Preparations for deuterium-tritium experiments on the Tokamak Fusion Test Reactor
- Author
-
Hawryluk, RJ, Adler, H, Alling, P, Ancher, C, Anderson, H, Anderson, JL, Anderson, JW, Arunasalam, V, Ascione, G, Aschroft, D, Barnes, CW, Barnes, G, Batchelor, DB, Bateman, G, Batha, S, Baylor, LA, Beer, M, Bell, MG, Biglow, TS, Bitter, M, Blanchard, W, Bonoli, P, Bretz, NL, Brunkhorst, C, Budny, R, Burgess, T, Bush, H, Bush, CE, Camp, R, Caorlin, M, Carnevale, H, Chang, Z, Chen, L, Cheng, CZ, Chrzanowski, J, Collazo, I, Collins, J, Coward, G, Cowley, S, Cropper, M, Darrow, DS, Daugert, R, DeLooper, J, Duong, H, Dudek, L, Durst, R, Efthimion, PC, Ernst, D, Faunce, J, Fonck, RJ, Fredd, E, Fredrickson, E, Fromm, N, Fu, GY, Furth, HP, Garzotto, V, Gentile, C, Gettelfinger, G, Gilbert, J, Gioia, J, Goldfinger, RC, Golian, T, Gorelenkov, N, Gouge, MJ, Grek, B, Grisham, LR, Hammett, G, Hanson, GR, Heidbrink, W, Hermann, HW, Hill, KW, Hirshman, S, Hoffman, DJ, Hosea, J, Hulse, RA, and Hsuan, H
- Abstract
The final hardware modifications for tritium operation have been completed for the Tokamak Fusion Test Reactor (TFTR) [Fusion Technol. 21, 1324 (1992)]. These activities include preparation of the tritium gas handling system, installation of additional neutron shielding, conversion of the toroidal field coil cooling system from water to a Fluorinert™ system, modification of the vacuum system to handle tritium, preparation, and testing of the neutral beam system for tritium operation and a final deuterium-deuterium (D-D) run to simulate expected deuterium-tritium (D-T) operation. Testing of the tritium system with low concentration tritium has successfully begun. Simulation of trace and high power D-T experiments using D-D have been performed. The physics objectives of D-T operation are production of ≈ 10 MW of fusion power, evaluation of confinement, and heating in deuteriumtritium plasmas, evaluation of α-particle heating of electrons, and collective effects driven by alpha particles and testing of diagnostics for confined a particles. Experimental results and theoretical modeling in support of the D-T experiments are reviewed. © 1994 American Institute of Physics.
- Published
- 1994
- Full Text
- View/download PDF
38. Recommendations for the electrometric determination of the pH of atmospheric wet deposition (acid rain)
- Author
-
Durst, R. A., Davison, W., and Koch, W. F.
- Published
- 1994
- Full Text
- View/download PDF
39. Identity-Based Internet Protocol Networking.
- Author
-
Nakamoto, G., Durst, R., Growney, C., Andresen, J., Ma, J., Trivedi, N., Quang, R., and Pisano, D.
- Abstract
The Identity-Based Internet Protocol (IBIP) Network project is experimenting with a new enterprise oriented network architecture using standard Internet Protocol to encode identity (ID) information into the IP packet by a new edge security device referred to as the IBIP policy enforcement point (PEP). This is a variant of a network admission control process that establishes user and host identities as well as provides optional information on host visibility, organizational affiliation, current role, and trust metric (associated with the user and host endpoints). Our motivation is to increase our security posture by leveraging identity, reducing our threat exposure, enhancing situational understanding of our environment, and simplifying network operations. In addition to authentication, we leverage strong anti-spoofing technology to improve accountability. We reduce our threat surface by “hiding” our client hosts and making all infrastructure devices inaccessible. Any attempt to access a hidden host or infrastructure device results in a policy violation attributable to the user/host that caused the violation and provides enhanced situational awareness of such activities. Our servers can also have a “permissible use” policy that ensures that the server only operates across the network per that policy. Finally, as users log in and servers are added to the network all dynamic configurations for access control initiated by such changes are automatically carried out without manual intervention, thereby reducing potential vulnerabilities caused by human errors. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
40. Formation Risk of Toxic and Other Unwanted Compounds in Pressure-Assisted Thermally Processed Foods.
- Author
-
Segovia Bravo, K., Ramírez, R., Durst, R., Escobedo-Avellaneda, Z.J., Welti-Chanes, J., Sanz, P.D., and Torres, J.A.
- Subjects
FOOD science ,CHEMICAL kinetics ,FOOD microbiology ,BACTERIAL spores ,ACRYLAMIDE ,APPROPRIATE technology for the food industry ,FOOD inspection - Abstract
Consumers demand, in addition to excellent eating quality, high standards of microbial and chemical safety in shelf-stable foods. This requires improving conventional processing technologies and developing new alternatives such as pressure-assisted thermal processing (PATP). Studies in PATP foods on the kinetics of chemical reactions at temperatures (approximately 100 to 120 °C) inactivating bacterial spores in low-acid foods are severely lacking. This review focuses on a specific chemical safety risk in PATP foods: models predicting if the activation volume value ( V
a ) of a chemical reaction is positive or negative, and indicating if the reaction rate constant will decrease or increase with pressure, respectively, are not available. Therefore, the pressure effect on reactions producing toxic compounds must be determined experimentally. A recent model solution study showed that acrylamide formation, a potential risk in PATP foods, is actually inhibited by pressure (that is, its Va value must be positive). This favorable finding was not predictable and still needs to be confirmed in food systems. Similar studies are required for other reactions producing toxic compounds including polycyclic aromatic hydrocarbons, heterocyclic amines, N-nitroso compounds, and hormone like-peptides. Studies on PATP inactivation of prions, and screening methods to detect the presence of other toxicity risks of PATP foods, are also reviewed. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
41. Comparison between two legal indications for compulsory outpatient treatment in Israel.
- Author
-
Teitelbaum A, Bar-El Y, Shlafman M, Durst R, Teitelbaum, Alexander, Bar-El, Yair, Shlafman, Michael, and Durst, Rimona
- Abstract
The aim of the present study was to compare the outcome of two legal indications for Compulsory Outpatient Treatment (COT) in Israel (a) as an alternative to compulsory hospitalization (CH) and (b) as a follow-up to CH. Demographic, clinical and legal measurements based on 326 COT orders issued in the Jerusalem and Southern district of Israel were compared according to the two legal provisions for COT contained in the Treatment of Mental Patients Law (1991). The COT order was found to be more effective when used as an alternative to CH (53.1%) than when it was used following CH (38.8%), p = 0.002. In the former case, there were fewer schizophrenic patients, fewer hospitalizations, fewer visits to psychiatric emergency services and longer remissions. Our results point to the influence of the legal indications on the efficacy of the COT order and help define the target population. [ABSTRACT FROM AUTHOR]
- Published
- 2004
42. A Parallel-Plate Resistive-Anode Gaseous Detector for X-Ray Imaging.
- Author
-
Khazins, D. M., Becker, B. L., Diawara, Y., Durst, R. D., He, B. B., Medved, S. A., Sedov, V., and Thorson, T. A.
- Subjects
GAS detectors ,ELECTRODES ,X-ray diffraction ,CHEMICAL detectors ,ELECTRIC resistors ,PHYSICS - Abstract
A novel gaseous detector, based on parallel-plate gas amplification with a resistive anode and remote readout electrode, is described. The detector is significantly less prone to discharges than other gaseous wireless detectors and unique in its ability to achieve high gain at high counting rates. A local counting rate >5 × 10&sup5; counts/mm²-s at a gas gain of up to 10
5 has been achieved in a 14 × 14 cm² area detector for diffraction applications. rrhe detector radiation hardness is characterized by the anode accumulated charge >100 Coul/cm². The detector is sealed and its regassing period is estimated to be 5-10 yr. The operating characteristics of the new detector, its spatial resolution, and linearity are described and preliminary X-ray diffraction data are presented. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
43. Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population.
- Author
-
Neumark YD, Friedlander Y, Durst R, Leitersdorf E, Jaffe D, Ramchandani VA, O'Connor S, Carr LG, and Li T
- Abstract
BACKGROUND: Genetic variation in the alcohol dehydrogenase (ADH) enzyme is associated with an aversion to alcohol and a lower risk of alcoholism among Asians. There is growing evidence of a functional role of the ADH2*2 allele in alcohol-drinking patterns among Jews, who have traditionally exhibited low rates of alcoholism and alcohol-related problems. The mechanism by which this allelic effect is mediated is not yet clearly understood. This study examined the effect of ADH2*2 on alcohol-elimination rates (AER) under experimental conditions. METHODS: Young adult male Jews (N = 109) received an intravenous alcohol infusion; metabolism was measured by using standard breath alcohol concentration tests. A clamping technique was used to achieve and maintain a target breath alcohol concentration of 50 mg/100 ml for a defined time period. The AER at steady state was calculated. The alcohol disappearance rate was also calculated from the descending limb slope. Polymerase chain reaction was used for allelic determination of the ADH2 and ADH3 loci. RESULTS: The mean AER among ADH2*2 carriers was significantly higher (8.09 +/- 1.4 g/hr) than among ADH2*1 homozygotes (7.14 +/- 1.5 g/hr; p = 0.003). Significance was retained on adjustment for potential confounding covariates. The ADH2 allele explains 8.5% of the AER variance in this population. Little AER difference was observed across ADH3 genotype groups. The slope of the descending limb increased with increasing copies of the ADH2*2 allele. CONCLUSIONS: The rate of alcohol elimination is significantly associated with the ADH2 genotype of Jewish males. Evidence for variation in alcohol metabolism across ADH genotypic groups provides support for the role of physiologic protective factors in alcohol drinking and suggests that reduced drinking among Jews may be genetically as well as environmentally determined. We believe that application of the novel 'Indiana clamp' enhances AER measurement accuracy, allowing for detection of hitherto undetectable differences. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
44. Kleptomania: diagnosis and treatment options.
- Author
-
Durst, R., Katz, G., Teitelbaum, A., Zislin, J., and Dannon, P.N.
- Subjects
- *
KLEPTOMANIA , *DRUGS - Abstract
Kleptomania--the inability to resist the impulse to steal objects, not for personal use or monetary gain--is currently classified in psychiatric nomenclature as an impulse control disorder. However, some of the principle features of the disorder, which include repetitive intrusion thoughts, inability to resist the compulsion to perform the thievery and the relief of tension following the act, suggest that kleptomania may constitute an obsessive-compulsive spectrum disorder. Kleptomania is commonly under-diagnosed and is often accompanied by other psychiatric conditions, most notably affective, anxiety and eating disorders, and alcohol and substance abuse. Individuals with the disorder are usually referred for treatment due to the comorbid psychiatric complaints rather than kleptomanic behaviour per se. Over the past century there has been a shift from psychotherapeutic to psychopharmacological interventions for kleptomania. Pharmacological management using selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) and other antidepressants, mood stabilisers and opioid receptor antagonists, as adjuvants to cognitive-behavioural therapy, has produced promising results. [ABSTRACT FROM AUTHOR]
- Published
- 2001
45. Jerusalem syndrome.
- Author
-
Bar-El, Yair, Durst, Rimona, Katz, Gregory, Zislin, Josef, Strauss, Ziva, Knobler, Haim Y., Bar-el, Y, Durst, R, Katz, G, Zislin, J, Strauss, Z, and Knobler, H Y
- Subjects
PSYCHOSES ,PATHOLOGICAL psychology ,PSYCHIATRISTS ,TRAVELERS ,SYNDROMES ,CHRISTIAN shrines ,SACRED space - Abstract
Background: Jerusalem's psychiatrists expect to encounter, as the millennium approaches, an ever-increasing number of tourists who, upon arriving in Jerusalem, may suffer psychotic decompensation.Aims: To describe the Jerusalem syndrome as a unique acute psychotic state.Method: This analysis is based on accumulated clinical experience and phenomenological data consisting of cultural and religious perspectives.Results: Three main categories of the syndrome are identified and described, with special focus on the category pertaining to spontaneous manifestations, unconfounded by previous psychotic history or psychopathology.Conclusions: The discrete form of the Jerusalem syndrome is related to religious excitement induced by proximity to the holy places of Jerusalem, and is indicated by seven characteristic sequential stages. [ABSTRACT FROM AUTHOR]- Published
- 2000
- Full Text
- View/download PDF
46. Towards a noninvasive assessment of valve biology: Echocardiographic measures of mitral leaflet distensibility
- Author
-
Szymanski, C., Hanschumacher, M., Messas, E., Dietz, H., Judge, D., Chaput, M., Durst, R., Dal Bianco, J., Morris, E., Marshall, J., Hagege, A., and Levine, R.
- Published
- 2011
- Full Text
- View/download PDF
47. The beam emission spectroscopy diagnostic on the DIII-D tokamak.
- Author
-
McKee, G., Ashley, R., Durst, R., Fonck, R., Jakubowski, M., Tritz, K., Burrell, K., Greenfield, C., and Robinson, J.
- Subjects
EMISSION spectroscopy ,TOKAMAKS ,PLASMA turbulence - Abstract
Describes the installation of a beam emission spectroscopy (BES) system on the DIII-D tokamak to provide localized density fluctuation measurements for long wavelength plasma turbulent modes which are typically associated with anomalous radial transport. Description of the D-III BES diagnostic system; Isolation of small fluctuation signal; Measurements of turbulence.
- Published
- 1999
- Full Text
- View/download PDF
48. Measurements of the radial structure and poloidal spectra of toroidal Alfvén eigenmodes in the Tokamak Fusion Test Reactor.
- Author
-
Durst, R. D., Fonck, R. J., Wong, K. L., Cheng, C. Z., Fredrickson, E. D., and Paul, S. F.
- Subjects
- *
MAGNETOHYDRODYNAMIC waves , *EIGENVALUES , *TOKAMAKS - Abstract
Toroidal Alfvén eigenmodes (TAE) have been excited by tangential neutral beam injection in the Tokamak Fusion Test Reactor (TFTR) [Proceedings of the Thirteenth International Conference on Plasma Physics and Controlled Nuclear Fusion Research, 1990, Washington, D.C. (International Atomic Energy Agency, Vienna, 1990), Vol. I, p. 9]. Beam emission spectroscopy (BES) has been used to study the radial structure and the poloidal power spectra of these modes. Radial profiles show a global, standing wave structure with a node near r/a=0.6 and a maximum displacement of about 5–10 mm. The cross-phase profiles and the power spectra both imply that the mode is composed of a mixture of components with various poloidal and toroidal mode numbers, as expected for the TAE. Measurements of the poloidal mode spectrum via BES show good agreement with theoretical simulations performed by a nonvariational, kinetic magnetohydrodynamics stability code (nova-k [Cheng, Phys. Rep. 211, 1 (1992)]). In particular, the dominant harmonics in the poloidal spectrum obey the expected relation m+1/2≊q(r)n. [ABSTRACT FROM AUTHOR]
- Published
- 1992
- Full Text
- View/download PDF
49. Investigation of global Alfvén instabilities in the Tokamak Fusion Test Reactor.
- Author
-
Wong, K. L., Durst, R., Fonck, R. J., Paul, S. F., Roberts, D. R., Fredrickson, E. D., Nazikian, R., Park, H. K., Bell, M., Bretz, N. L., Budny, R., Cheng, C. Z., Cohen, S., Hammett, G. W., Jobes, F. C., Johnson, L., Meade, D. M., Medley, S. S., and Mueller, D.
- Subjects
- *
MAGNETOHYDRODYNAMIC waves , *EIGENFUNCTIONS , *ION bombardment , *PLASMA gases , *MAGNETIC fields - Abstract
Toroidal Alfvén eigenmodes (TAE) were excited by the energetic neutral beam ions tangentially injected into plasmas at low magnetic field in the Tokamak Fusion Test Reactor (TFTR) [Proceedings of the 11th International Conference on Plasma Physics and Controlled Fusion Research (IAEA, Vienna, 1987), Vol. 1, p. 51]. The injection velocities were comparable to the Alfvén speed. The modes were identified by measurements from Mirnov coils and beam emission spectroscopy (BES). TAE modes appear in bursts whose repetition rate increases with beam power. The neutron emission rate exhibits sawtoothlike behavior and the crashes always coincide with TAE bursts. This indicates ejection of fast ions from the plasma until these modes are stabilized. The dynamics of growth and stabilization were investigated at various plasma currents and magnetic fields. The results indicate that the instability can effectively clamp the number of energetic ions in the plasmas. The observed instability threshold is discussed in light of recent theories. In addition to these TAE modes, intermittent oscillations at three times the fundamental TAE frequency were observed by Mirnov coils, but no corresponding signal was found in BES. It appears that these high-frequency oscillations do not have a direct effect on the plasma neutron source strength. [ABSTRACT FROM AUTHOR]
- Published
- 1992
- Full Text
- View/download PDF
50. Density fluctuation measurements via beam emission spectroscopy (invited).
- Author
-
Durst, R. D., Fonck, R. J., Cosby, G., Evensen, H., and Paul, S. F.
- Subjects
- *
PLASMA gases , *TURBULENCE - Abstract
Previous studies of plasma microturbulence have indicated that the fluctuation power scales with radial wave number, k[sub ⊥], like k[sup -2, sub ⊥ → k[sup -3.5, sub ⊥] for k[sub ⊥] > 2 cm[sup -1]. This implies that low k fluctuations may dominate the spectrum. Beam emission spectroscopy (BES) has been developed to provide spatially localized measurements of density fluctuations in this low k region of the spectrum (k[sub ⊥] <2 cm[sup -1]). A 20-channel system has been installed on TFTR which images one of the heating neutral beams (via fiber optics) onto a set of photoconductive photodiode detectors. Fluctuations in the fluorescent D[sub α] emission from the beam can be related to the local plasma density fluctuations via a model of the atomic excitation processes. The analysis of BES data utilizes many of the standard statistical analysis techniques such as power spectra, coherency and cross phase, and correlation analysis which are also used in the analysis of, for example, Langmuir probe data. In the case of BES however, these techniques require some special modifications to account for systematic effects such as photon statistics and fluctuations in the neutral beam density induced by the strong fluctuations near the plasma edge. [ABSTRACT FROM AUTHOR]
- Published
- 1992
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.